fda warning letters compounded semaglutide tirzepatide 2025 Issues 30 to Telehealth Firms Over Misleading GLP-1 Marketing FDA Issues Warning Letters to

Community sources describe this combination as producing markedly larger GH pulses than either peptide alone

Understanding these mechanisms helps contextualize why hair changes might occur during treatment with weight loss medications like tirzepatide, even if the medication itself is not directly affecting hair follicles

The Swiss study compared 1.5 mg weekly doses of dulaglutide (Trulicity, Eli Lilly) with placebo, varenicline and counseling as a control for 12-week abstinence confirmed by carbon monoxide breath testing

Difficulty swallowing (dysphagia) or pain when swallowing, which may indicate oesophageal complications and requires urgent assessment at any age